Edition:
India

People: TherapeuticsMD Inc (TXMD.OQ)

TXMD.OQ on NASDAQ Stock Exchange Global Select Market

2.49USD
26 Jun 2019
Change (% chg)

-- (--)
Prev Close
$2.49
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
887,787
52-wk High
$7.04
52-wk Low
$2.21

Milligan, John 

Mr. John C.K. Milligan IV is President, Secretary and Director of TherapeuticsMD, Inc., since October 2011. From December 2008 to October 2011, Mr. Milligan has served as President, Secretary, and a director of our company since October 2011. From December 2008 to October 2011, Mr. Milligan served as President and director of VitaMed. Prior to VitaMed, Mr. Milligan co-founded CareFusion, LLC, serving as President and General Manager from August 2001 to February 2008, and then as President and Chief Operating Officer of CareFusion, Inc. From 1997 to 2001, Mr. Milligan was Vice President, Sales and Operations for Omnicell, Inc. Prior to Omnicell, Mr. Milligan also held executive management positions at Serving Software Inc. and HBO & Co., a health care information systems company, both of which were subsequently acquired by McKesson Corporation. We believe Mr. Milligan’s significant experience in creating, developing and guiding growth-oriented health care companies and knowledge of our business provide the requisite qualifications, skills, perspectives, and experience that make him well qualified to serve on our Board of Directors. Mr. Milligan is a graduate of the U.S. Naval Academy.

Basic Compensation

Total Annual Compensation, USD 528,750
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 1,172,680
Fiscal Year Total, USD 1,701,430

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 2,032,255 10,542,800.00
Name Fiscal Year Total

Tommy Thompson

378,308

John Milligan

1,701,430

Robert Finizio

2,724,580

Brian Bernick

1,297,940

Daniel Cartwright

1,245,480

Michael Donegan

703,480
As Of  31 Dec 2018